Heritage Wealth Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Heritage Wealth Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-113	Closed	-$616	–	561
2023 Q3	$616	Hold	113	–	–	﹤0.01%	482
2023 Q2	$758	Hold	113	–	–	﹤0.01%	518
2023 Q1	$998	Hold	113	–	–	﹤0.01%	532
2022 Q4	$863	Hold	113	–	–	﹤0.01%	525
2022 Q3	$805	Hold	113	–	–	﹤0.01%	501
2022 Q2	$1K	Hold	113	–	–	﹤0.01%	530
2022 Q1	$2K	Hold	113	–	–	﹤0.01%	498
2021 Q4	$3K	Hold	113	–	–	﹤0.01%	497
2021 Q3	$3.84K	Hold	113	–	–	﹤0.01%	485
2021 Q2	$4.62K	Buy	+113	New	+$4.39K	﹤0.01%	487

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Heritage Wealth Advisors's ADPT Position: Q4 2023 in Review

Heritage Wealth Advisors sold out of Adaptive Biotechnologies (ADPT) in Q4 2023, closing a stake of 113 shares — an estimated $616 sold.

Heritage Wealth Advisors first reported a position in ADPT in Q2 2021 and held it in 10 quarters. The position peaked at $4.62K in Q2 2021. 200 funds tracked by Wall St. Rank hold ADPT as of Q4 2023.

Heritage Wealth Advisors reported no remaining Adaptive Biotechnologies position as of Q4 2023 after selling out during the quarter.
Heritage Wealth Advisors sold 113 Adaptive Biotechnologies shares in Q4 2023, an estimated $616.
Heritage Wealth Advisors first reported a position in Adaptive Biotechnologies in Q2 2021 and held it in 10 quarters.
Heritage Wealth Advisors's Adaptive Biotechnologies position peaked at $4.62K in Q2 2021.
200 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2023.

Based on Heritage Wealth Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.